Hint mode is switched on Switch off

BIB - ProShares Ultra Nasdaq Biotechnology (USD) (US74347R2141)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Choose all Reset all

Leveraged

 
(%)
US74347R2141
BIB ISIN
Exchange Traded Funds (ETF)
Type of fund
ProShares
Provider
79.42 USD
NAV per Share | 03/06/2026
07/04/2010
Inception Date
4 times per year
Dividend payments
CEOJLS
CFI
BIB
Ticker
Formed
Status
Equity
Investment category
Biotech
Sector
USA
Investor locations
Nasdaq Biotechnology® Index
Benchmark
0.95 %
Total Cost Ratio
69.09 mln USD
Fund NAV | 03/06/2026
69.09 mln USD
Share Class NAV | 03/06/2026
No
UCITS

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Yield on 03/06/2026, NASDAQ

  • YTD
    -2.97 %
  • 1M
    -13.62 %
  • 3M
    -11.24 %
  • 6M
    -0.65 %
  • 1Y
    81.38 %
  • 3Y
    46.02 %
  • 5Y
    -4.77 %
  • 10Y
    -
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (BIB)

Explore the most comprehensive database

1 000 000

bonds

80 234

stocks

167 970

ETF & Funds

70 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

BIB profile

The ProShares Ultra Nasdaq Biotechnology (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The ProShares fund’s base currency is USD and the share class was registered 07.04.2010 with unique ISIN - US74347R2141. Main exchange is NASDAQ and ticker symbol is BIB. The total expense ratio is 0.95%. The ProShares Ultra Nasdaq Biotechnology (USD) pays dividends 4 time(s) per year.

Structure BIB on 03/06/2026

Download structure in Excel
Paper Value
LIGAND PHARMACEUTICALS 0%
VERACYTE INC 0%
EDGEWISE THERAPEUTICS INC 0%
AMNEAL PHARMACEUTICALS INC 0%
ERASCA INC 0%
TRAVERE THERAPEUTICS INC 0%
CARIS LIFE SCIENCES INC 0%
INDIVIOR PHARMACEUTICALS INC 0%
TWIST BIOSCIENCE CORP 0%
XENON PHARMACEUTICALS INC 0%
SCHOLAR ROCK HOLDING CORP 0%
CG ONCOLOGY INC 0%
APOGEE THERAPEUTICS INC 0%
10X GENOMICS INC-CLASS A 0%
CENTESSA PHARMACEUTICALS-ADR 0%
CRISPR THERAPEUTICS AG 0%
COGENT BIOSCIENCES INC 0%
ABIVAX SA-ADR 0%
MIRUM PHARMACEUTICALS INC 0%
PTC THERAPEUTICS INC 0%
SPYRE THERAPEUTICS INC 0%
RHYTHM PHARMACEUTICALS INC 0%
KYMERA THERAPEUTICS INC 0%
PROTAGONIST THERAPEUTICS INC 0%
IMMUNOVANT INC 0%
ARCUTIS BIOTHERAPEUTICS INC 0%
AURINIA PHARMACEUTICALS INC 0%
ENLIVEN THERAPEUTICS INC 0%
ULTRAGENYX PHARMACEUTICAL IN 0%
KINIKSA PHARMACEUTICALS INTE 0%
VERA THERAPEUTICS INC 0%
DEFINIUM THERAPEUTICS INC 0%
GRAIL INC 0%
ADAPTIVE BIOTECHNOLOGIES 0%
IDEAYA BIOSCIENCES INC 0%
TARSUS PHARMACEUTICALS INC 0%
SUPERNUS PHARMACEUTICALS INC 0%
ALUMIS INC 0%
NUVALENT INC-A 0%
DISC MEDICINE INC 0%
RELAY THERAPEUTICS INC 0%
ORUKA THERAPEUTICS INC 0%
TANGO THERAPEUTICS INC 0%
STRUCTURE THERAPEUTICS INC 0%
DYNE THERAPEUTICS INC 0%
BEAM THERAPEUTICS INC 0%
LEGEND BIOTECH CORP-ADR 0%
DENALI THERAPEUTICS INC 0%
CRINETICS PHARMACEUTICALS IN 0%
ACADIA PHARMACEUTICALS INC 0%
VERTEX PHARMACEUTICALS INC 0%
MODERNA INC 0%
INCYTE CORP 0%
ROIVANT SCIENCES LTD 0%
INSMED INC 0%
ARGENX SE - ADR 0%
ROYALTY PHARMA PLC- CL A 0%
UNITED THERAPEUTICS CORP 0%
ILLUMINA INC 0%
BIOGEN INC 0%
REVOLUTION MEDICINES INC 0%
ALNYLAM PHARMACEUTICALS INC 0%
REGENERON PHARMACEUTICALS 0%
VIATRIS INC 0%
GILEAD SCIENCES INC 0%
AMGEN INC 0%
THIRD HARMONIC BIO INC 0%
CARTESIAN THERAPEUTICS-CVR 0%
NEWAMSTERDAM PHARMA CO NV 0%
PROSHARES GENIUS MNY MKT ETF 0%
NASDAQ Biotechnology Index SWAP UBS AG 0%
NASDAQ Biotechnology Index SWAP Societe Generale 0%
NASDAQ Biotechnology Index SWAP Goldman Sachs International 0%
NASDAQ Bio Index SWAP BNP Paribas 0%
NASDAQ Biotechnology Index SWAP Bank of America NA 0%
BIOMARIN PHARMACEUTICAL INC 0%
VAXCYTE INC 0%
ALKERMES PLC 0%
IMMUNITYBIO INC 0%
PRAXIS PRECISION MEDICINES I 0%
HALOZYME THERAPEUTICS INC 0%
TEMPUS AI INC-CL A 0%
CYTOKINETICS INC 0%
KRYSTAL BIOTECH INC 0%
BEONE MEDICINES LTD-ADR 0%
BIONTECH SE-ADR 0%
ARROWHEAD PHARMACEUTICALS IN 0%
SANOFI-ADR 0%
NASDAQ Biotechnology Index SWAP Citibank NA 0%
MADRIGAL PHARMACEUTICALS INC 0%
SUMMIT THERAPEUTICS INC 0%
AXSOME THERAPEUTICS INC 0%
IONIS PHARMACEUTICALS INC 0%
BRIDGEBIO PHARMA INC 0%
MEDPACE HOLDINGS INC 0%
ASCENDIS PHARMA A/S 0%
EXELIXIS INC 0%
JAZZ PHARMACEUTICALS PLC 0%
NEUROCRINE BIOSCIENCES INC 0%
GUARDANT HEALTH INC 0%
Show more Hide
Other - %

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.